CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Qianjiang Yongan Pharmaceutical Co Ltd Company Snapshot
Qianjiang Yongan Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Qianjiang Yongan Pharmaceutical Co Ltd with three other companies in this sector in CHINA : Huaren Pharmaceutical Co Ltd (2019 sales of 1.46 billion Chinese Renmimbi [US$215.88 million] of which 91% was Medicine Industry), CSPC Innovation Pharmaceutical Co Ltd (1.26 billion Chinese Renmimbi [US$185.55 million] of which 69% was Caffeine Division), and Tibet Cheezheng Tibetan Medicine Co Ltd (1.40 billion Chinese Renmimbi [US$207.13 million] of which 100% was Drug).

Sales Analysis. During the year ended December of 2019, sales at Qianjiang Yongan Pharmaceutical Co Ltd were 1.37 billion Chinese Renmimbi (US$202.37 million). This is an increase of 36.3% versus 2018, when the company's sales were 1.01 billion Chinese Renmimbi. This was the third consecutive year of growth at Qianjiang Yongan Pharmaceutical Co Ltd. Sales of Healthy Food Products saw an increase of 46.6% in 2019, from 68.42 million Chinese Renmimbi to 100.28 million Chinese Renmimbi. Not all segments of Qianjiang Yongan Pharmaceutical Co Ltd experienced an increase in sales in 2019: sales of Other Main Business fell 93.6% to 10.54 million Chinese Renmimbi. Qianjiang Yongan Pharmaceutical Co Ltd also experienced decreases in sales in Medical Manufacturing (down 25.7% to 573.84 million Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Qianjiang Yongan Pharmaceutical Co Ltd
  Stock Performance Chart for Qianjiang Yongan Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/18/2020): 12.05
(Figures in Chinese Renmimbi)
1 Week 0.2%   13 Weeks -5.9%  
4 Weeks 0.0%   52 Weeks 32.1%  
 
Qianjiang Yongan Pharmaceutical Co Ltd Key Data:
  Ticker: 002365 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2019 Sales 1,370,443,052
(Year Ending Jan 2020).
Employees: 944
  Currency: Chinese Renmimbi Market Cap: 3,380,025,856
  Fiscal Yr Ends: December Shares Outstanding: 280,500,071
  Share Type: Gu Closely Held Shares: 91,450,615
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.